Literature DB >> 19488047

Understanding what determines the frequency and pattern of human germline mutations.

Norman Arnheim1, Peter Calabrese.   

Abstract

Surprising findings about human germline mutation have come from applying new technologies to detect rare mutations in germline DNA, from analysing DNA sequence divergence between humans and closely related species, and from investigating human polymorphic variation. In this Review we discuss how these approaches affect our current understanding of the roles of sex, age, mutation hot spots, germline selection and genomic factors in determining human nucleotide substitution mutation patterns and frequencies. To enhance our understanding of mutation and disease, more extensive molecular data on the human germ line with regard to mutation origin, DNA repair, epigenetic status and the effect of newly arisen mutations on gamete development are needed.

Entities:  

Mesh:

Year:  2009        PMID: 19488047      PMCID: PMC2744436          DOI: 10.1038/nrg2529

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  150 in total

1.  Transgenerational mutation by radiation.

Authors:  Y E Dubrova; M Plumb; B Gutierrez; E Boulton; A J Jeffreys
Journal:  Nature       Date:  2000-05-04       Impact factor: 49.962

2.  The cell cycle and DNA mismatch repair.

Authors:  Allen G Schroering; Michael A Edelbrock; Timothy J Richards; Kandace J Williams
Journal:  Exp Cell Res       Date:  2006-10-26       Impact factor: 3.905

Review 3.  Mechanisms giving rise to triploid zygotes during assisted reproduction.

Authors:  Bernd E Rosenbusch
Journal:  Fertil Steril       Date:  2007-10-22       Impact factor: 7.329

Review 4.  Review and hypotheses: somatic mosaicism: observations related to clinical genetics.

Authors:  J G Hall
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

Review 5.  DNA repair in mammalian embryos.

Authors:  Souraya Jaroudi; Sioban SenGupta
Journal:  Mutat Res       Date:  2006-12-01       Impact factor: 2.433

6.  Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming.

Authors:  Hugh D Morgan; Wendy Dean; Heather A Coker; Wolf Reik; Svend K Petersen-Mahrt
Journal:  J Biol Chem       Date:  2004-09-24       Impact factor: 5.157

7.  Failure to recognize multiple endocrine neoplasia 2B: more common than we think?

Authors:  Curtis J Wray; Thereasa A Rich; Steven G Waguespack; Jeffrey E Lee; Nancy D Perrier; Douglas B Evans
Journal:  Ann Surg Oncol       Date:  2007-10-26       Impact factor: 5.344

8.  The methyl-CpG-binding protein MeCP2 and neurological disease.

Authors:  Adrian Bird
Journal:  Biochem Soc Trans       Date:  2008-08       Impact factor: 5.407

9.  Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells.

Authors:  J P Rossiter; M Young; M L Kimberland; P Hutter; R P Ketterling; J Gitschier; J Horst; M A Morris; D J Schaid; P de Moerloose
Journal:  Hum Mol Genet       Date:  1994-07       Impact factor: 6.150

10.  The impact of recombination on nucleotide substitutions in the human genome.

Authors:  Laurent Duret; Peter F Arndt
Journal:  PLoS Genet       Date:  2008-05-09       Impact factor: 5.917

View more
  58 in total

1.  Pervasive multinucleotide mutational events in eukaryotes.

Authors:  Daniel R Schrider; Jonathan N Hourmozdi; Matthew W Hahn
Journal:  Curr Biol       Date:  2011-06-21       Impact factor: 10.834

2.  Human disease: Germline selection for deleterious mutation in males.

Authors:  Tanita Casci
Journal:  Nat Rev Genet       Date:  2012-03-06       Impact factor: 53.242

Review 3.  Measurements of spontaneous rates of mutations in the recent past and the near future.

Authors:  Fyodor A Kondrashov; Alexey S Kondrashov
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-04-27       Impact factor: 6.237

4.  ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant.

Authors:  Julia Haupt; Alexandra Deichsel; Katja Stange; Cindy Ast; Renata Bocciardi; Roberto Ravazzolo; Maja Di Rocco; Paola Ferrari; Antonio Landi; Frederick S Kaplan; Eileen M Shore; Carsten Reissner; Petra Seemann
Journal:  Hum Mol Genet       Date:  2014-05-22       Impact factor: 6.150

Review 5.  On the sequence-directed nature of human gene mutation: the role of genomic architecture and the local DNA sequence environment in mediating gene mutations underlying human inherited disease.

Authors:  David N Cooper; Albino Bacolla; Claude Férec; Karen M Vasquez; Hildegard Kehrer-Sawatzki; Jian-Min Chen
Journal:  Hum Mutat       Date:  2011-09-02       Impact factor: 4.878

Review 6.  Epigenetics and the origins of paternal effects.

Authors:  James P Curley; Rahia Mashoodh; Frances A Champagne
Journal:  Horm Behav       Date:  2010-07-08       Impact factor: 3.587

Review 7.  De novo mutations in human genetic disease.

Authors:  Joris A Veltman; Han G Brunner
Journal:  Nat Rev Genet       Date:  2012-07-18       Impact factor: 53.242

8.  Cis-suppression to arrest protein aggregation in mammalian cells.

Authors:  Simpson Gregoire; Shaojie Zhang; Joseph Costanzo; Kelly Wilson; Erik J Fernandez; Inchan Kwon
Journal:  Biotechnol Bioeng       Date:  2013-10-18       Impact factor: 4.530

9.  The ups and downs of mutation frequencies during aging can account for the Apert syndrome paternal age effect.

Authors:  Song-Ro Yoon; Jian Qin; Rivka L Glaser; Ethylin Wang Jabs; Nancy S Wexler; Rebecca Sokol; Norman Arnheim; Peter Calabrese
Journal:  PLoS Genet       Date:  2009-07-10       Impact factor: 5.917

10.  Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors.

Authors:  Anne Goriely; Ruth M S Hansen; Indira B Taylor; Inge A Olesen; Grete Krag Jacobsen; Simon J McGowan; Susanne P Pfeifer; Gilean A T McVean; Ewa Rajpert-De Meyts; Andrew O M Wilkie
Journal:  Nat Genet       Date:  2009-10-25       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.